GLP-1 Series: Week 5 Side Effects: From Common to Serious side effects..What You Should Know

Throughout our GLP-1 educational series, we’ve talked about how these medications work, the importance of protecting muscle, and why eating less doesn’t necessarily mean eating better.

This week we’re discussing something equally important:

Side effects.

GLP-1 medications can produce significant changes in appetite, digestion and blood sugar. Those effects can also come with unwanted symptoms. Some are relatively common and temporary. Others are uncommon but potentially serious.

Being educated about these risks isn’t about frightening anyone or telling someone whether they should or shouldn’t take a medication.

It’s about informed decision-making.

The Most Common Side Effects

The most frequently reported side effects of GLP-1 receptor agonists involve the gastrointestinal system.

These can include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal discomfort

• Indigestion or reflux

• Bloating and burping

These symptoms frequently occur when treatment begins or when the dose is increased, and for many people they improve with time. (PubMed Central (PMC)⁠)

But “common” doesn’t mean symptoms should always be ignored.

Persistent vomiting or diarrhea can lead to dehydration and potentially contribute to kidney problems. Severe or persistent gastrointestinal symptoms deserve a conversation with your healthcare provider.

Slowing Down the Digestive System

Remember what we learned earlier in this series: GLP-1 receptor activation can slow gastric emptying, meaning food can remain in the stomach longer.

That’s part of how these medications increase feelings of fullness.

But slowing digestion can also contribute to nausea, vomiting, bloating and other gastrointestinal symptoms.

There is another reason this matters.

Delayed gastric emptying can result in food remaining in the stomach despite fasting before surgery or a medical procedure. This has raised concerns about aspiration during anesthesia and deep sedation. (PubMed Central (PMC)⁠)

If you’re taking a GLP-1 medication and are having surgery or a procedure requiring sedation, make sure the medical and anesthesia teams know.

Gallstones and Gallbladder Disease

This is one of the risks for which we have fairly strong evidence.

A large meta-analysis of 76 randomized clinical trials involving more than 100,000 participants found that GLP-1 receptor agonist treatment was associated with an increased risk of gallbladder and biliary disease, including gallstones and gallbladder inflammation. The association was greater in weight-loss trials and with higher doses and longer treatment duration. (PubMed⁠)

Rapid weight loss itself can also increase the risk of gallstones.

So this isn’t necessarily a simple question of medication versus no medication. Weight loss, medication effects and changes in gallbladder function may all contribute. (PubMed Central (PMC)⁠)

What About Pancreatitis?

You’ve probably heard pancreatitis mentioned in conversations about GLP-1 medications.

Acute pancreatitis is included as a warning in current FDA prescribing information for medications such as Wegovy. Symptoms can include severe, persistent abdominal pain that may radiate into the back, sometimes accompanied by nausea or vomiting. (FDA Access Data⁠)

But there’s an important distinction between a warning and proof that a medication substantially increases the risk.

Large randomized-trial analyses have not consistently demonstrated an increased rate of acute pancreatitis with GLP-1 receptor agonists. A recent systematic review of 55 randomized trials found an increased risk of gallstones but not pancreatitis. (PubMed Central (PMC)⁠)

So the most accurate statement is:

Pancreatitis has occurred in people taking these medications and remains an important clinical warning, but current randomized-trial evidence has not established a large increased risk.

Regardless of the cause, severe persistent abdominal pain should never simply be dismissed as a normal medication side effect.

Kidney Problems and Dehydration

GLP-1 medications aren’t generally considered directly toxic to healthy kidneys.

The concern can arise when gastrointestinal side effects become severe.

Repeated vomiting or diarrhea can cause significant fluid loss. Dehydration can reduce blood flow to the kidneys and contribute to acute kidney injury, particularly in people who already have kidney problems or take certain other medications.

This is another reason hydration matters—and why persistent vomiting shouldn’t be viewed simply as evidence that the medication is “working.”

Low Blood Sugar

GLP-1 medications stimulate insulin in a glucose-dependent manner, so when used alone they generally have a relatively low risk of causing severe hypoglycemia.

The situation changes when they’re combined with medications that can independently lower blood glucose, particularly insulin or sulfonylureas.

Those combinations can increase the risk of hypoglycemia.

People using multiple diabetes medications may need their treatment adjusted by their healthcare provider.

What About the Eyes?

This deserves particular attention in people with diabetes.

Rapid improvement in blood glucose can temporarily worsen existing diabetic retinopathy in some individuals. This phenomenon isn’t unique to GLP-1 medications; it has previously been observed when blood glucose improves rapidly through other treatments as well.

People with diabetes—especially those with existing retinopathy or very elevated blood glucose—should make sure they’re receiving appropriate eye care while undergoing major changes in glucose control. (PubMed⁠)

Thyroid Tumor Warning

Some GLP-1 medications, including semaglutide, carry an FDA boxed warning concerning thyroid C-cell tumors.

Here’s the important context.

Thyroid C-cell tumors occurred in rodents exposed to these medications.

It has not been established that semaglutide causes medullary thyroid carcinoma in humans.

Because of the animal findings, these medications are generally contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Research into the long-term human thyroid cancer question continues. A recent scientific review noted that this remains an area requiring continued investigation. (PubMed⁠)

Not Every Reported Problem Means the Medication Caused It

This is extremely important when discussing medication safety.

If someone experiences a medical problem while taking a medication, that doesn’t automatically mean the medication caused it.

That’s why researchers use randomized clinical trials, observational studies, adverse-event surveillance and long-term follow-up.

Sometimes a safety signal becomes stronger as more evidence accumulates.

Sometimes subsequent research shows that an apparent association wasn’t actually caused by the medication.

Good science requires us to acknowledge both possibilities.

When Should You Seek Medical Attention?

Someone taking a GLP-1 medication should contact a healthcare professional promptly for concerning or persistent symptoms.

Seek urgent medical evaluation for symptoms such as severe or persistent abdominal pain—particularly pain radiating to the back—repeated vomiting with inability to keep fluids down, signs of significant dehydration, symptoms suggesting a severe allergic reaction, or other severe or rapidly worsening symptoms.

Don’t assume every symptom is simply part of losing weight.

The Bigger Conversation

The popularity of these medications has exploded.

For some people with obesity, diabetes or cardiovascular risk, research has demonstrated meaningful benefits.

But benefit doesn’t mean risk-free.

And weight loss doesn’t automatically mean healthier.

Every medication deserves the same questions:

What are the potential benefits?

What are the known risks?

What don’t we know yet?

How long has this particular medication and dose been studied?

What happens with long-term use?

And is the benefit worth the potential risk for this individual person?

Those are conversations worth having with a knowledgeable healthcare professional.

The Bottom Line

Most people who experience side effects from GLP-1 medications experience gastrointestinal symptoms such as nausea, diarrhea, vomiting or constipation.

But there are also less common and potentially serious complications and warnings involving the gallbladder, pancreas, kidneys, eyes and other systems.

Some associations are well established.

Others remain uncertain.

And some questions will require additional years of research.

That’s exactly why we’re doing this series.

You deserve to understand not only what a medication may do FOR you, but also what it may potentially do TO you.

Education allows you to ask better questions and make better-informed decisions about your health.

Coming in Week 6

GLP-1 Medications and the Pancreas

We’ll take a deeper look at acute pancreatitis, whether pancreatitis can become chronic, the established relationship between chronic pancreatitis and pancreatic cancer, and what research actually tells us—and doesn’t tell us—about GLP-1 medications and pancreatic cancer.

This article is for educational purposes only and is not medical advice. Never start, stop or change a prescription medication without discussing it with your healthcare provider.

Body Blast Fitness Studio

Real Women. Real Lives. Real Results.